Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

BCAX vs IRWD: stock comparison and AI forecast

Bicara Therapeutics Inc. (BCAX) and Ironwood Pharmaceuticals Inc (IRWD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

BCAX Bicara Therapeutics Inc.

Price
$8.96 -61.3% · 6M
Market Cap
$593M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

IRWD Ironwood Pharmaceuticals Inc

Price
$3.50 -25.1% · 6M
Market Cap
$578M
P/E Ratio
10.9x
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-05 → 2026-11-04

Six-month price performance

Closing prices rebased to 100 at the start of the window.

5075100125
BCAX -61.3% IRWD -25.1%
BCAX · IRWD

Key facts

  • BCAX and IRWD have similar market capitalizations ($593M and $578M).
  • Over the last six months IRWD returned -25.1% and BCAX -61.3%.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricBCAXIRWD
Market Cap$593M$578M
P/E Ratio–10.94x
P/B Ratio1.26x–
EPS$-2.84$0.32
Book Value/Share$7.08–
Revenue/Share–$2.61
FCF/Share$-2.04–

Profitability & Margins

MetricBCAXIRWD
ROE-39.5%–
ROA-36.2%–
ROIC-43.1%92.8%
Operating Margin–54.4%
EBT Margin–48.2%
Tax Rate-0.1%37.4%

Financial Health

MetricBCAXIRWD
Current Ratio11.59x6.06x
D/E Ratio0.09x–
Financial Leverage1.09x–
Interest Coverage–0.2x
Working Capital$460M$166M

Cash Flow

MetricBCAXIRWD
Operating Cash Flow-$135M$186M
Free Cash Flow-$135M–
Capital Spending-$400K–
OCF Growth YoY–518.8%

Operational Efficiency

MetricBCAXIRWD
Asset Turnover–1.51x
Receivables Turnover–3.8x
Fixed Assets Turnover–147.8x
Days Sales Outstanding–96 days

Income Statement

MetricBCAXIRWD
Total Revenue–$430M
Operating Income-$202M$234M
Net Income-$185M–
R&D Expense$140M$89M
SG&A Expense–$65M

Dividend & Shareholder Information

MetricBCAXIRWD
Shares Outstanding66M165M
EPS Growth–100.0%
FAQ

BCAX vs IRWD: stock comparison and AI forecast

Which is bigger, BCAX or IRWD?

BCAX and IRWD have similar market capitalizations ($593M and $578M).

Which stock performed better over the last six months, BCAX or IRWD?

Over the last six months IRWD returned -25.1% and BCAX -61.3%.

Which one does Intratio's AI model rank higher, BCAX or IRWD?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.